drugset / Trial / NCT03882983
Stromal Vascular Fraction From Lipoaspirate to Treatment of Chronic Non-healing Wound
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase I, open-label, single arm study to demonstrate the safety of Antria Cell Preparation Process during fat grafting augmented with autologous adipose derived stromal vascular fraction to demonstrate the safety and efficacy of administration of SVF enriched fat grafting in chronic wounds
Timeline
- Start
- 2017-09-01
- Primary completion
- 2022-12
- Completion
- 2022-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rexlemestrocel-L | Cell therapy | — | — |